ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 1076

Assessing the Reliability of ChatGPT on Recombinant Zoster Vaccination for Patients with Rheumatic and Musculoskeletal Diseases

Akhil Sood, Pegah Jahangiri, Amanda Moyer and Janice Lin, Stanford University, Palo Alto, CA

Meeting: ACR Convergence 2024

Keywords: Clinical practice guidelines, education, medical, education, patient, informatics

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Date: Sunday, November 17, 2024

Title: Measures & Measurement of Healthcare Quality Poster

Session Type: Poster Session B

Session Time: 10:30AM-12:30PM

Background/Purpose: As artificial intelligence (AI) platforms continue to evolve, large language models (LLMs) such as ChatGPT by OpenAI are increasingly being utilized by patients and healthcare providers as a source of health information. However, it is crucial to consider the advantages and limitations of such platforms. The objective of the study is to assess the accuracy and completeness of responses generated by ChatGPT compared to validated information resources on recombinant Zoster vaccination in patients with rheumatic and musculoskeletal diseases (RMD).

Methods: In this cross-sectional study, twenty prompts derived from three validated sources of information on recombinant Zoster vaccine were entered into ChatGPT 3.5. The sources included: 1) the Centers for Disease Control and Prevention (CDC), with information from both ‘What Everyone Should Know’ and ‘Healthcare Professionals’ sections; 2) guideline recommendations from the Advisory Committee on Immunization Practices (ACIP); and 3) the American College of Rheumatology (ACR). These guidelines were framed as questions and inputted as prompts into ChatGPT. The responses generated by ChatGPT were assessed for accuracy (5-Point Likert Scale 1 – completely incorrect to 5 – completely correct) and completeness (3-Point scale 1-incomplete to 3-complete) in comparison with the validated information source by five rheumatologists. Scores of accuracy and completeness of the ChatGPT responses were listed descriptively and compared between information sources using non-parametric testing.

Results: The overall mean accuracy on a 5-point scale was 4.04 +/- 1.22, with 80% of responses scoring ≥ 4. The mean completeness score on a 3-point scale was 2.3 +/-0.63, with 95% of responses scoring ≥2. ChatGPT responses to prompts based on ACIP recommendations scored highest in accuracy (Mean 4.5 +/- 0.71) and completeness (Mean 2.4+/-0.70). It scored lowest in accuracy (Mean 3.6+/- 1.37) and completeness (Mean 2.2 +/- 0.65) to prompts based on ACR guidelines. There were no significant differences in accuracy or completeness when comparing ChatGPT responses between information sources (Kruskal-Wallis p-value > 0.05).

Conclusion: ChatGPT 3.5 is a reliable LLM that can accurately and comprehensively answer specific questions regarding recombinant Zoster vaccine for patients with RMDs. However, responses may deviate from evidence-based guidelines. ChatGPT responses should be interpreted with caution. As LLMs evolve, it is essential to ensure that information from multiple validated sources is built into the AI model.

Supporting image 1

Table 1: Descriptive statistics of accuracy and completeness scores of ChatGPT responses by information source

Supporting image 2

Figure 1: Boxplot showing the distribution of accuracy scores of ChatGPT responses by information source

Supporting image 3

Figure 2: Boxplot showing the distribution of completeness scores of ChatGPT responses by information source


Disclosures: A. Sood: None; P. Jahangiri: None; A. Moyer: None; J. Lin: None.

To cite this abstract in AMA style:

Sood A, Jahangiri P, Moyer A, Lin J. Assessing the Reliability of ChatGPT on Recombinant Zoster Vaccination for Patients with Rheumatic and Musculoskeletal Diseases [abstract]. Arthritis Rheumatol. 2024; 76 (suppl 9). https://acrabstracts.org/abstract/assessing-the-reliability-of-chatgpt-on-recombinant-zoster-vaccination-for-patients-with-rheumatic-and-musculoskeletal-diseases/. Accessed .
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to ACR Convergence 2024

ACR Meeting Abstracts - https://acrabstracts.org/abstract/assessing-the-reliability-of-chatgpt-on-recombinant-zoster-vaccination-for-patients-with-rheumatic-and-musculoskeletal-diseases/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology